Comparison of oral ibuprofen and indomethacin on closure of patent ductus arteriosus in preterm infants

Eastern Mediterranean Health Journal

Volumn 14, Issue 2, 2008, Pages 360-365

  Pourarian, Sh ^a   Pishva, N ^a   Madani, A ^a   Rastegari, M ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; INDOMETACIN;

ARTICLE; BLEEDING TENDENCY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEART SURGERY; HUMAN; HYPERBILIRUBINEMIA; INFANT; IRAN; LENGTH OF STAY; MALE; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PHOTOTHERAPY; PREMATURITY; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS; SIDE EFFECT; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL;

ADMINISTRATION, ORAL; BLOOD UREA NITROGEN; CARDIOVASCULAR AGENTS; CREATININE; CYCLOOXYGENASE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INTENSIVE CARE UNITS, NEONATAL; IRAN; MALE; SUSPENSIONS; TREATMENT OUTCOME;

EID: 45849092276     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Lemons JA et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 Through December 1996. Pediatrics, 2001, 107:E1.
2. Hammoud MS et al. Incidence and risk factors associated with the patency of ductus arteriosus in preterm infants with respiratory distress syndrome in Kuwait. Saudi medical journal, 2003, 24(9): 982-5.
3. Clyman RI. Medical treatment of patent ductus arteriosus in premature infants. In: Long WA, ed. Fetal and neonatal cardiology. Philadelphia: WB Saunders, 1990:682-90.
4. Varvarigou A et al. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. Journal of the American Medical Association, 1996, 275(7):539-44.
5. Lago P et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. European journal of pediatrics, 2002, 161(4):202-7.
6. Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. Journal of the Medical Association of Thailand, 2002, 85(Suppl. 4):S1252-8.
7. Chotigeat U, Jirapapa K, Layangkool T. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. Journal of the Medical Association of Thailand, 2003, 86(Suppl. 3):S563-9.
8. Behrman RE, Kliegman RM, Jensen HB. Nelson textbook of pediatrics, 17th ed. Philadelphia, Saunders, 2004: 580.
9. Patel J et al. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatric research, 2000, 47(1)36-42.
10. Mosca F et al. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. Journal of pediatrics, 1997, 131(4):549-54.
11. Pezzati M et al. Effects of indomethacin and ibuprofen on mesentric and renal blood flow in preterm infants with patent ductus arteriosus. Journal of pediatrics, 1999, 135(6):733-8.
12. De Carolis MP et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. European journal of pediatrics, 2000, 159(5):364-8.
13. Dani C et al. Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants. Acta paediatrica, 2000, 89(11):1369-74.
14. Gournay V et al. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet, 2002, 359(9316):1486-8.